These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31730630)

  • 21. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
    Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
    PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mother-child separation among women living with HIV and their children in the first four years postpartum in South Africa.
    Mogoba P; Phillips TK; le Roux S; Mukonda EE; Brittain K; Gomba Y; Zerbe A; Abrams EJ; Myer L
    Trop Med Int Health; 2021 Feb; 26(2):173-183. PubMed ID: 33159710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
    Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation and Operational Research: Postpartum Transfer of Care Among HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy.
    Phillips T; McNairy ML; Zerbe A; Myer L; Abrams EJ
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e102-9. PubMed ID: 26470033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
    Levison JH; Wood R; Scott CA; Ciaranello AL; Martinson NA; Rusu C; Losina E; Freedberg KA; Walensky RP
    Clin Infect Dis; 2013 Feb; 56(4):587-97. PubMed ID: 23087386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiated models of care for postpartum women on antiretroviral therapy in Cape Town, South Africa: a cohort study.
    Myer L; Iyun V; Zerbe A; Phillips TK; Brittain K; Mukonda E; Allerton J; Kalombo CD; Nofemela A; Abrams EJ
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21636. PubMed ID: 28770593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia.
    De Broucker G; Salvatore PP; Mutembo S; Moyo N; Mutanga JN; Thuma PE; Moss WJ; Sutcliffe CG
    PLoS One; 2021; 16(3):e0248217. PubMed ID: 33690733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lay health worker programmes on the health outcomes of mother-child pairs of HIV exposed children in Africa: A scoping review.
    Schmitz K; Basera TJ; Egbujie B; Mistri P; Naidoo N; Mapanga W; Goudge J; Mbule M; Burtt F; Scheepers E; Igumbor J
    PLoS One; 2019; 14(1):e0211439. PubMed ID: 30703152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township.
    Tomlinson M; Doherty T; Ijumba P; Jackson D; Lawn J; Persson LÅ; Lombard C; Sanders D; Daviaud E; Nkonki L; Goga A; Rohde S; Sitrin D; Colvin M; Chopra M
    Trop Med Int Health; 2014 Mar; 19(3):256-266. PubMed ID: 24433230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L; Phillips TK
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with non-attendance at scheduled infant follow-up visits in an observational cohort of HIV-exposed infants in South Africa, 2012-2014.
    Ngandu NK; Jackson D; Lombard C; Nsibande DF; Dinh TH; Magasana V; Mogashoa M; Goga AE
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):788. PubMed ID: 31526372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness.
    Bassett IV; Govindasamy D; Erlwanger AS; Hyle EP; Kranzer K; van Schaik N; Noubary F; Paltiel AD; Wood R; Walensky RP; Losina E; Bekker LG; Freedberg KA
    PLoS One; 2014; 9(1):e85197. PubMed ID: 24465503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study.
    Frank SC; Cohn J; Dunning L; Sacks E; Walensky RP; Mukherjee S; Dugdale CM; Turunga E; Freedberg KA; Ciaranello AL
    Lancet HIV; 2019 Mar; 6(3):e182-e190. PubMed ID: 30737187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
    Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
    AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa.
    Schneider K; Nwizu C; Kaplan R; Anderson J; Wilson DP; Emery S; Cooper DA; Boyd MA
    PLoS One; 2013; 8(2):e54435. PubMed ID: 23457450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study.
    Alba C; Malhotra S; Horsfall S; Barnhart ME; Bekker A; Chapman K; Cunningham CK; Fast PE; Fouda GG; Freedberg KA; Goga A; Ghazaryan LR; Leroy V; Mann C; McCluskey MM; McFarland EJ; Muturi-Kioi V; Permar SR; Shapiro R; Sok D; Stranix-Chibanda L; Weinstein MC; Ciaranello AL; Dugdale CM
    medRxiv; 2023 Nov; ():. PubMed ID: 37986879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.
    Mwapasa V; Joseph J; Tchereni T; Jousset A; Gunda A
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S123-S131. PubMed ID: 28498181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
    Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
    PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.